News: Acura Pharmaceuticals Inc (ACUR.OQ)
ACUR.OQ on NASDAQ Stock Exchange Capital Market
1.98USD
1 Aug 2013
1.98USD
1 Aug 2013
Price Change (% chg)
$-0.06 (-2.94%)
$-0.06 (-2.94%)
Prev Close
$2.04
$2.04
Open
$1.99
$1.99
Day's High
$2.01
$2.01
Day's Low
$1.90
$1.90
Volume
57,968
57,968
Avg. Vol
92,365
92,365
52-wk High
$4.49
$4.49
52-wk Low
$1.06
$1.06
Select another date:
Select another date:
- Small-Cap Picks From Last Week's 13D/G 5% Ownership Fund Manager Filings
- Acura Pharmaceuticals Is Grossly Undervalued And Poised For Rapid Growth
- No Relief in Sight for Pain Investors
- Acura Pharmaceuticals Management Discusses Q1 2013 Results - Earnings Call Transcript
- Why Did Pain Therapeutics Increase Over 25%?
- Society And The FDA Are Ready For Acura, Are You?
Press Releases
- Acura Pharmaceuticals Launches Next Generation Cold Medicine to Aid in the Fight Against Meth
- Acura Pharmaceuticals Announces Successful Bioequivalent Study for NEXAFED
- Acura Pharmaceuticals Announces Third Quarter 2012 Financial Results
- Acura Pharmaceuticals to Host Third Quarter 2012 Financial Results Conference Call on November 7, 2012
- Acura Pharmaceuticals Announces Earlier Return of Development Products
- Acura Pharmaceuticals Announces Paragraph IV ANDA Filing for OXECTA(R)
- Acura Pharmaceuticals to Present at the Stifel Nicolaus Healthcare Conference on September 5, 2012
- Acura Pharmaceuticals Supports the Stop Tampering of Prescription Pills Act of 2012
- Acura Pharmaceuticals Announces Second Quarter 2012 Financial Results
- Acura Pharmaceuticals Announces Update on AVERSION Products

